DNA Origami‐Templated Aptamer Chiral Structures Realize Cellular Enantioselectivity
Advanced Materials · 2026-02 · 38 (12)
DOI: 10.1002/adma.202519007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 16.01.2026. Verfasst von Tingjie Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, DNA Nanostructures, Drug Carriers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Science Foundation, NIH HHS.
Abstract (Originalsprache)
Chirality refers to handedness as left‐ or right‐handed form of a molecule or molecular construct by synthesis or self‐assembly. In biology, chirality plays critical roles in determining the structures and functions of biomolecules such as proteins. In this study, we demonstrated that structural chirality generated by patterning multiple cell surface protein biomarker‐binding aptamers on a tubular‐shaped DNA origami (“DNA tube”) can realize differentness in cellular interaction, nanostructure uptake, cancer drug delivery, and consequent cell killing. Formation of the DNA tube and its ability to arrange external elements into left‐ or right‐handed form have been characterized by gel electrophoresis, atomic force microscopy, and transmission electron microscopy. Our fluorescence‐based cell experiments showed that the DNA tube‐templated aptamers of a left‐handed pattern can yield a higher cell uptake than those in a right‐form pattern. When loaded with an anticancer drug, Daunorubicin (Dau), the left‐handed tube‐aptamer‐Dau construct showed greater than double the cancer cell cytotoxicity than the construct in the right‐handed. Our study not only revealed that cell surface proteins interaction with the aptamers spatially organized into different chiral patterns can yield different cellular interaction and internalization efficiencies, but offered a new and versatile cancer drug delivery strategy for enhanced target cell treatment efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
- Holonyak Micro and Nanotechnology Lab, Grainger College of Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
- Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
- Department of Bioengineering, Grainger College of Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
- Department of Electrical and Computer Engineering, Grainger College of Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
- Department of Advanced Manufacturing and Robotics, Peking University, Beijing, China.
ORCID-Profile: Tingjie Song, Abhisek Dwivedy, Dhanush Gandavadi, Gayatri Chandran, Mengxi Zheng, Xiaojing Wang, Lifeng Zhou, Yang Zhao, Xing Wang
Förderung
- NIGMS NIH HHS
- National Science Foundation
- NIH HHS
- National Institutes of Health
Zitieren
APA
Song, T., Dwivedy, A., Gandavadi, D., Chandran, G., An, Y., Zheng, M., Wang, X., Zhou, L., Zhao, Y., & Wang, X. (2026). DNA Origami‐Templated Aptamer Chiral Structures Realize Cellular Enantioselectivity. Advanced Materials, 38(12). https://doi.org/10.1002/adma.202519007
Vancouver
Song T, Dwivedy A, Gandavadi D, Chandran G, An Y, Zheng M, et al. DNA Origami‐Templated Aptamer Chiral Structures Realize Cellular Enantioselectivity. Advanced Materials. 2026;38(12). doi:10.1002/adma.202519007
BibTeX
@article{Song2026,
author = {Song, Tingjie and Dwivedy, Abhisek and Gandavadi, Dhanush and Chandran, Gayatri and An, Yiquan and Zheng, Mengxi and Wang, Xiaojing and Zhou, Lifeng and Zhao, Yang and Wang, Xing},
title = {DNA Origami‐Templated Aptamer Chiral Structures Realize Cellular Enantioselectivity},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {12},
doi = {10.1002/adma.202519007}
}
EUVIMED